Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Biotech rivals clash as Arrowhead sues Ionis over RNA-based triglyceride therapy Arrowhead sues Ionis over APOC3 patent dispute as plozasiran nears FDA approval. Discover what’s at stake in this RNA-based biotech rivalry. byPallavi MadhirajuSeptember 11, 2025